MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacc.2018.04.072

Медицинская библиотека · Journal of the American College of Cardiology · 2018

Ventricular Assist Device Support as a Bridge to Transplantation in Pediatric Patients.

Dipchand Anne I, Kirk Richard, Naftel David C, Pruitt Elizabeth, Blume Elizabeth D, Morrow Robert, Rosenthal David, Auerbach Scott, Richmond Marc E, Kirklin James K, Pediatric Heart Transplant Study Investigators

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Pediatric ventricular assist device (VAD) use has evolved dramatically over the last 2 decades.

OBJECTIVES

This study sought to describe the evolution of VAD support to heart transplantation (HTx) in children in a large international multicenter cohort.

METHODS

Using data from the Pediatric Heart Transplant Study, comparisons were made between children (<18 years) supported to HTx (January 1, 1993 to December 31, 2015) with VAD or extracorporeal membrane oxygenation (ECMO) to VAD support.

RESULTS

Of 7,135 listed patients, 5,145 underwent HTx; 995 (19.3%) were supported by a VAD (113 with congenital heart disease [CHD]). Patients with a VAD as their first device (n = 821) were older, larger, and more likely to have cardiomyopathy (80%) than patients transitioned from ECMO to VAD (n = 164). In the VAD-only cohort, 79% underwent HTx and 14% died, compared with 69% and 24% in the ECMO-to-VAD cohort, respectively. Patients with cardiomyopathy achieved HTx 84% of the time, with a 9% waitlist mortality rate compared with 55% and 36%, respectively, for CHD. Among VAD-treated patients, 79% were age >10 years in the earliest era, a percentage decreasing to 34% more recently, though neonates still represent <1%. Overall, survival at 2 and 20 years showed no difference between VAD and no support (2 years: 75% vs. 80%; 20 years: 55% vs. 54%). Post-HTx outcomes were better for durable versus temporary VADs (p < 0.01) and for continuous versus pulsatile VADs (p < 0.01) from 2005 onward; timing of VAD had no impact on post-HTx survival (p = 0.65).

CONCLUSIONS

For one-quarter of a century, major advances have occurred in mechanical support technology for children, thereby expanding the capability to bridge to HTx without compromising post-HTx outcomes. Significant challenges remain, especially for neonates and patients with CHD, but ongoing innovation portends improved methods of support during the next decade.

Для цитирования: Dipchand Anne I, Kirk Richard, Naftel David C, Pruitt Elizabeth, Blume Elizabeth D, Morrow Robert, Rosenthal David, Auerbach Scott, Richmond Marc E, Kirklin James K, Pediatric Heart Transplant Study Investigators. Ventricular Assist Device Support as a Bridge to Transplantation in Pediatric Patients.. Journal of the American College of Cardiology. 2018. DOI: 10.1016/j.jacc.2018.04.072.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.